Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Pediatric Quality of Life Inventory (PedsQL) in Fragile X Syndrome.

Fitzpatrick SE, Schmitt LM, Adams R, Pedapati EV, Wink LK, Shaffer RC, Sage J, Weber JD, Dominick KC, Erickson CA.

J Autism Dev Disord. 2019 Nov 14. doi: 10.1007/s10803-019-04292-7. [Epub ahead of print]

PMID:
31728808
2.

Associations of race and ethnicity with risk of developing invasive breast cancer after lobular carcinoma in situ.

Dania V, Liu Y, Ademuyiwa F, Weber JD, Colditz GA.

Breast Cancer Res. 2019 Nov 14;21(1):120. doi: 10.1186/s13058-019-1219-8.

PMID:
31727116
3.

DHX33 Interacts with AP-2β To Regulate Bcl-2 Gene Expression and Promote Cancer Cell Survival.

Wang J, Feng W, Yuan Z, Weber JD, Zhang Y.

Mol Cell Biol. 2019 Aug 12;39(17). pii: e00017-19. doi: 10.1128/MCB.00017-19. Print 2019 Sep 1.

PMID:
31182639
4.

Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ.

Liu Y, West R, Weber JD, Colditz GA.

Cancer. 2019 Sep 15;125(18):3225-3233. doi: 10.1002/cncr.32200. Epub 2019 May 23.

5.

Correction to: Imaging features of immune-mediated genitourinary disease.

Weber JD, Hammond N, Yaghmai V, Nikolaidis P, Miller FH, Horowitz JM.

Abdom Radiol (NY). 2019 Aug;44(8):2956. doi: 10.1007/s00261-019-02050-y.

PMID:
31076832
6.

Mitochondrial fusion supports increased oxidative phosphorylation during cell proliferation.

Yao CH, Wang R, Wang Y, Kung CP, Weber JD, Patti GJ.

Elife. 2019 Jan 29;8. pii: e41351. doi: 10.7554/eLife.41351.

7.

Voice of People with Fragile X Syndrome and Their Families: Reports from a Survey on Treatment Priorities.

Weber JD, Smith E, Berry-Kravis E, Cadavid D, Hessl D, Erickson C.

Brain Sci. 2019 Jan 23;9(2). pii: E18. doi: 10.3390/brainsci9020018.

8.

The Role of RNA Editing in Cancer Development and Metabolic Disorders.

Kung CP, Maggi LB Jr, Weber JD.

Front Endocrinol (Lausanne). 2018 Dec 18;9:762. doi: 10.3389/fendo.2018.00762. eCollection 2018. Review.

9.

Best Practices in Fragile X Syndrome Treatment Development.

Erickson CA, Kaufmann WE, Budimirovic DB, Lachiewicz A, Haas-Givler B, Miller RM, Weber JD, Abbeduto L, Hessl D, Hagerman RJ, Berry-Kravis E.

Brain Sci. 2018 Dec 15;8(12). pii: E224. doi: 10.3390/brainsci8120224.

10.

Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer.

Wagner AH, Devarakonda S, Skidmore ZL, Krysiak K, Ramu A, Trani L, Kunisaki J, Masood A, Waqar SN, Spies NC, Morgensztern D, Waligorski J, Ponce J, Fulton RS, Maggi LB Jr, Weber JD, Watson MA, O'Conor CJ, Ritter JH, Olsen RR, Cheng H, Mukhopadhyay A, Can I, Cessna MH, Oliver TG, Mardis ER, Wilson RK, Griffith M, Griffith OL, Govindan R.

Nat Commun. 2018 Sep 17;9(1):3787. doi: 10.1038/s41467-018-06162-9.

11.

Varieties of social experience: The religious cultural context of diverse spiritual exemplars.

King PE, Abo-Zena MM, Weber JD.

Br J Dev Psychol. 2017 Mar;35(1):127-141. doi: 10.1111/bjdp.12181.

PMID:
28220951
12.

Sabotaging of the oxidative stress response by an oncogenic noncoding RNA.

Mahajan N, Wu HJ, Bennett RL, Troche C, Licht JD, Weber JD, Maggi LB Jr, Tomasson MH.

FASEB J. 2017 Feb;31(2):482-490. doi: 10.1096/fj.201600654R. Epub 2016 Oct 24.

13.

DHX33 Transcriptionally Controls Genes Involved in the Cell Cycle.

Yuan B, Wang X, Fan C, You J, Liu Y, Weber JD, Zhong H, Zhang Y.

Mol Cell Biol. 2016 Nov 14;36(23):2903-2917. doi: 10.1128/MCB.00314-16. Print 2016 Dec 1.

14.

Feasibility of the Ultrasonic Bone Aspirator in Retrosigmoid Vestibular Schwannoma Removal.

Golub JS, Weber JD, Leach JL, Pottschmidt NR, Zuccarello M, Pensak ML, Samy RN.

Otolaryngol Head Neck Surg. 2015 Sep;153(3):427-32. doi: 10.1177/0194599815587485. Epub 2015 Jun 5.

PMID:
26048419
15.

Targeting PTEN-defined breast cancers with a one-two punch.

Maggi LB Jr, Weber JD.

Breast Cancer Res. 2015 Apr 8;17:51. doi: 10.1186/s13058-015-0566-3.

16.

Reduction of bone dust with ultrasonic bone aspiration: implications for retrosigmoid vestibular schwannoma removal.

Weber JD, Samy RN, Nahata A, Zuccarello M, Pensak ML, Golub JS.

Otolaryngol Head Neck Surg. 2015 Jun;152(6):1102-7. doi: 10.1177/0194599815573198. Epub 2015 Mar 9.

PMID:
25754180
17.

Elevated DDX21 regulates c-Jun activity and rRNA processing in human breast cancers.

Zhang Y, Baysac KC, Yee LF, Saporita AJ, Weber JD.

Breast Cancer Res. 2014 Sep 28;16(5):449. doi: 10.1186/s13058-014-0449-z.

18.

Age-dependent sensitization of cutaneous nociceptors during developmental inflammation.

Jankowski MP, Ross JL, Weber JD, Lee FB, Shank AT, Hudgins RC.

Mol Pain. 2014 Jun 7;10:34. doi: 10.1186/1744-8069-10-34.

19.

ARF and p53 coordinate tumor suppression of an oncogenic IFN-β-STAT1-ISG15 signaling axis.

Forys JT, Kuzmicki CE, Saporita AJ, Winkeler CL, Maggi LB Jr, Weber JD.

Cell Rep. 2014 Apr 24;7(2):514-526. doi: 10.1016/j.celrep.2014.03.026. Epub 2014 Apr 13.

20.

ARF tumor suppression in the nucleolus.

Maggi LB Jr, Winkeler CL, Miceli AP, Apicelli AJ, Brady SN, Kuchenreuther MJ, Weber JD.

Biochim Biophys Acta. 2014 Jun;1842(6):831-9. doi: 10.1016/j.bbadis.2014.01.016. Epub 2014 Feb 10. Review.

21.

Posttranscriptional control of T cell effector function by aerobic glycolysis.

Chang CH, Curtis JD, Maggi LB Jr, Faubert B, Villarino AV, O'Sullivan D, Huang SC, van der Windt GJ, Blagih J, Qiu J, Weber JD, Pearce EJ, Jones RG, Pearce EL.

Cell. 2013 Jun 6;153(6):1239-51. doi: 10.1016/j.cell.2013.05.016.

22.

Forget transcription: translation is where the action is.

Maggi LB Jr, Weber JD.

Mol Cell Biol. 2013 May;33(10):1884-5. doi: 10.1128/MCB.00231-13. Epub 2013 Mar 18. No abstract available.

23.

P19ARF and RasV¹² offer opposing regulation of DHX33 translation to dictate tumor cell fate.

Zhang Y, Saporita AJ, Weber JD.

Mol Cell Biol. 2013 Apr;33(8):1594-607. doi: 10.1128/MCB.01220-12. Epub 2013 Feb 11.

24.

The ARF tumor-suppressor controls Drosha translation to prevent Ras-driven transformation.

Kuchenreuther MJ, Weber JD.

Oncogene. 2014 Jan 16;33(3):300-7. doi: 10.1038/onc.2012.601. Epub 2013 Jan 14.

25.

Involvement of the mRNA binding protein CRD-BP in the regulation of metastatic melanoma cell proliferation and invasion by hypoxia.

Craig EA, Weber JD, Spiegelman VS.

J Cell Sci. 2012 Dec 15;125(Pt 24):5950-4. doi: 10.1242/jcs.115204. Epub 2012 Oct 4.

26.

Cathepsin K-Cre causes unexpected germline deletion of genes in mice.

Winkeler CL, Kladney RD, Maggi LB Jr, Weber JD.

PLoS One. 2012;7(7):e42005. doi: 10.1371/journal.pone.0042005. Epub 2012 Jul 31.

27.

Deconvoluting mTOR biology.

Weber JD, Gutmann DH.

Cell Cycle. 2012 Jan 15;11(2):236-48. doi: 10.4161/cc.11.2.19022. Epub 2012 Jan 15. Review.

28.

Hypergrowth mTORC1 signals translationally activate the ARF tumor suppressor checkpoint.

Miceli AP, Saporita AJ, Weber JD.

Mol Cell Biol. 2012 Jan;32(2):348-64. doi: 10.1128/MCB.06030-11. Epub 2011 Nov 7.

29.

Loss of Trop2 promotes carcinogenesis and features of epithelial to mesenchymal transition in squamous cell carcinoma.

Wang J, Zhang K, Grabowska D, Li A, Dong Y, Day R, Humphrey P, Lewis J, Kladney RD, Arbeit JM, Weber JD, Chung CH, Michel LS.

Mol Cancer Res. 2011 Dec;9(12):1686-95. doi: 10.1158/1541-7786.MCR-11-0241. Epub 2011 Oct 4.

30.

RNA helicase DDX5 is a p53-independent target of ARF that participates in ribosome biogenesis.

Saporita AJ, Chang HC, Winkeler CL, Apicelli AJ, Kladney RD, Wang J, Townsend RR, Michel LS, Weber JD.

Cancer Res. 2011 Nov 1;71(21):6708-17. doi: 10.1158/0008-5472.CAN-11-1472. Epub 2011 Sep 21.

31.

Identification of DHX33 as a mediator of rRNA synthesis and cell growth.

Zhang Y, Forys JT, Miceli AP, Gwinn AS, Weber JD.

Mol Cell Biol. 2011 Dec;31(23):4676-91. doi: 10.1128/MCB.05832-11. Epub 2011 Sep 19.

32.

The ARF tumor suppressor regulates bone remodeling and osteosarcoma development in mice.

Rauch DA, Hurchla MA, Harding JC, Deng H, Shea LK, Eagleton MC, Niewiesk S, Lairmore MD, Piwnica-Worms D, Rosol TJ, Weber JD, Ratner L, Weilbaecher KN.

PLoS One. 2010 Dec 30;5(12):e15755. doi: 10.1371/journal.pone.0015755.

33.

Tuberous sclerosis complex 1: an epithelial tumor suppressor essential to prevent spontaneous prostate cancer in aged mice.

Kladney RD, Cardiff RD, Kwiatkowski DJ, Chiang GG, Weber JD, Arbeit JM, Lu ZH.

Cancer Res. 2010 Nov 1;70(21):8937-47. doi: 10.1158/0008-5472.CAN-10-1646. Epub 2010 Oct 12.

34.

Identification of FUSE-binding protein 1 as a regulatory mRNA-binding protein that represses nucleophosmin translation.

Olanich ME, Moss BL, Piwnica-Worms D, Townsend RR, Weber JD.

Oncogene. 2011 Jan 6;30(1):77-86. doi: 10.1038/onc.2010.404. Epub 2010 Aug 30.

35.

Synthetic lethality through combined Notch-epidermal growth factor receptor pathway inhibition in basal-like breast cancer.

Dong Y, Li A, Wang J, Weber JD, Michel LS.

Cancer Res. 2010 Jul 1;70(13):5465-74. doi: 10.1158/0008-5472.CAN-10-0173. Epub 2010 Jun 22.

36.

Nucleolar disruption ensures nuclear accumulation of p21 upon DNA damage.

Abella N, Brun S, Calvo M, Tapia O, Weber JD, Berciano MT, Lafarga M, Bachs O, Agell N.

Traffic. 2010 Jun;11(6):743-55. doi: 10.1111/j.1600-0854.2010.01063.x. Epub 2010 Mar 19.

37.

Nucleophosmin redistribution following heat shock: a role in heat-induced radiosensitization.

Vanderwaal RP, Maggi LB Jr, Weber JD, Hunt CR, Roti Roti JL.

Cancer Res. 2009 Aug 15;69(16):6454-62. doi: 10.1158/0008-5472.CAN-08-4896. Epub 2009 Jul 28.

38.

Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation.

Brady SN, Maggi LB Jr, Winkeler CL, Toso EA, Gwinn AS, Pelletier CL, Weber JD.

Oncogene. 2009 Sep 10;28(36):3209-20. doi: 10.1038/onc.2009.178. Epub 2009 Jun 29.

39.

PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer.

Crowder RJ, Phommaly C, Tao Y, Hoog J, Luo J, Perou CM, Parker JS, Miller MA, Huntsman DG, Lin L, Snider J, Davies SR, Olson JA Jr, Watson MA, Saporita A, Weber JD, Ellis MJ.

Cancer Res. 2009 May 1;69(9):3955-62. doi: 10.1158/0008-5472.CAN-08-4450. Epub 2009 Apr 14.

40.

Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome.

Maggi LB Jr, Kuchenruether M, Dadey DY, Schwope RM, Grisendi S, Townsend RR, Pandolfi PP, Weber JD.

Mol Cell Biol. 2008 Dec;28(23):7050-65. doi: 10.1128/MCB.01548-07. Epub 2008 Sep 22.

41.

A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and function.

Apicelli AJ, Maggi LB Jr, Hirbe AC, Miceli AP, Olanich ME, Schulte-Winkeler CL, Saporita AJ, Kuchenreuther M, Sanchez J, Weilbaecher K, Weber JD.

Mol Cell Biol. 2008 Feb;28(3):1068-80. Epub 2007 Dec 10.

42.

Therapeutic targets in the ARF tumor suppressor pathway.

Saporita AJ, Maggi LB Jr, Apicelli AJ, Weber JD.

Curr Med Chem. 2007;14(17):1815-27. Review.

43.

Deacetylation of the retinoblastoma tumour suppressor protein by SIRT1.

Wong S, Weber JD.

Biochem J. 2007 Nov 1;407(3):451-60.

44.

Nucleophosmin mediates mammalian target of rapamycin-dependent actin cytoskeleton dynamics and proliferation in neurofibromin-deficient astrocytes.

Sandsmark DK, Zhang H, Hegedus B, Pelletier CL, Weber JD, Gutmann DH.

Cancer Res. 2007 May 15;67(10):4790-9.

45.

Mammalian target of rapamycin: master regulator of cell growth in the nervous system.

Sandsmark DK, Pelletier C, Weber JD, Gutmann DH.

Histol Histopathol. 2007 Aug;22(8):895-903. doi: 10.14670/HH-22.895. Review.

PMID:
17503347
46.

c-Fms tyrosine 559 is a major mediator of M-CSF-induced proliferation of primary macrophages.

Takeshita S, Faccio R, Chappel J, Zheng L, Feng X, Weber JD, Teitelbaum SL, Ross FP.

J Biol Chem. 2007 Jun 29;282(26):18980-90. Epub 2007 Apr 9.

47.

TSC1 sets the rate of ribosome export and protein synthesis through nucleophosmin translation.

Pelletier CL, Maggi LB Jr, Brady SN, Scheidenhelm DK, Gutmann DH, Weber JD.

Cancer Res. 2007 Feb 15;67(4):1609-17.

48.

A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum-resistant ovarian and primary peritoneal malignancies.

Seiden MV, Burris HA, Matulonis U, Hall JB, Armstrong DK, Speyer J, Weber JD, Muggia F.

Gynecol Oncol. 2007 Mar;104(3):727-31. Epub 2006 Nov 28.

PMID:
17126894
49.

Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex.

Lin DI, Barbash O, Kumar KG, Weber JD, Harper JW, Klein-Szanto AJ, Rustgi A, Fuchs SY, Diehl JA.

Mol Cell. 2006 Nov 3;24(3):355-66.

50.

Nucleophosmin is essential for ribosomal protein L5 nuclear export.

Yu Y, Maggi LB Jr, Brady SN, Apicelli AJ, Dai MS, Lu H, Weber JD.

Mol Cell Biol. 2006 May;26(10):3798-809.

Supplemental Content

Loading ...
Support Center